Vireo Growth Inc.
VREOF · Pharmaceutical Preparations
Latest available SEC filing: 4 ·
Latest disclosures
-
Steiner Michael L.: Form 4
Insider disclosure · Filed · Report period 03 Nov 2026
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Latest financial period: Q2 2026
Financial facts · Filed
-
Form 10-Q
SEC filing · Filed
-
Form 3
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
Company details and SEC sources
CIK 0001771706 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- VREOF on OTC
- SEC industry group
- Pharmaceutical Preparations (Office of Life Sciences)
- Business address
- 207 South 9 Th Street, Minneapolis, MN, 55402
- Incorporated in
- British Columbia, Canada
- Fiscal year end
- 31 December
- Former names on EDGAR
- Goodness Growth Holdings, Inc. (to 24 Jun 2024), Vireo Health International, Inc. (to 14 May 2021)
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields